BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 8567315)

  • 1. Lipoprotein(a) and other risk factors for cerebral infarction.
    Konemori G
    Hiroshima J Med Sci; 1995 Sep; 44(3):65-77. PubMed ID: 8567315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipoprotein (a) and cerebral infarction in young adults].
    Cao GF; Yang QD; Liu YH; Li HY; Xu HW; Xia J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May; 24(5):397-400. PubMed ID: 12820936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation of pentanucleotide repeat polymorphism of apolipoprotein (a) gene to plasma lipoprotein (a) level among Chinese patients with myocardial infarction and cerebral infarction].
    Liu X; Sun L; Li Z; Gao Y; Hui R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1396-400. PubMed ID: 12509922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of lipid and lipoprotein(a) to ischaemic stroke.
    Misirli H; Somay G; Ozbal N; Yaşar Erenoğlu N
    J Clin Neurosci; 2002 Mar; 9(2):127-32. PubMed ID: 11922698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors in atherothrombotic cerebral infarct. Are there differential risk profiles in extensive cortical infarct and lacunar infarct? A case-control study].
    Gómez Isla T; Ferrero Arias J
    Med Clin (Barc); 1990 Nov; 95(15):561-7. PubMed ID: 2090891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.
    Murase T; Okubo M; Amemiya-Kudo M; Hiraga T; Oka J; Shimada M; Igarashi T
    Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein (a) and lipid and non-lipid risk factors in coronaries risk assessment.
    Agoşton-Coldea L; Rusu LD; Zdrenghea D; Rusu ML; Pop D; Crăciun A; Poanta L; Gatfossé M; Rosenstingl S; Mocan T
    Rom J Intern Med; 2008; 46(2):137-44. PubMed ID: 19284085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
    Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
    Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) in cerebrovascular and coronary atherosclerosis.
    Nomura S
    Hiroshima J Med Sci; 1995 Dec; 44(4):133-9. PubMed ID: 8857237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke.
    Sharobeem KM; Patel JV; Ritch AE; Lip GY; Gill PS; Hughes EA
    Int J Clin Pract; 2007 Nov; 61(11):1824-8. PubMed ID: 17935546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
    Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
    Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum lipids, lipoprotein and stroke].
    Peng D; Zhao S
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):167-70. PubMed ID: 11938781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study on the relationship between Lp(a) and arteriosclerotic cerebral infarction].
    Tan Y; Yao C; Shen J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Feb; 19(1):36-8. PubMed ID: 10322706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apo(a) phenotype as a risk factor for the silent brain infarction].
    Notsu Y; Nabika T; Masuda J; Kobayashi S
    Rinsho Byori; 1997 Feb; 45(2):122-6. PubMed ID: 9120995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
    Imhof A; Rothenbacher D; Khuseyinova N; Hoffmeister A; Maerz W; Nauck M; Scharnagl H; Koenig W; Brenner H
    Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):362-70. PubMed ID: 14663298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus.
    Wakabayashi I; Masuda H
    Clin Chim Acta; 2006 Nov; 373(1-2):127-31. PubMed ID: 16820145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on the risk factors of cerebral infarction as complication of type 2 diabetes mellitu patients].
    Meng Q; Wang J; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Jun; 22(3):208-11. PubMed ID: 11860880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk levels of lipoprotein(a) in Pakistani patients with type 2 diabetes mellitus.
    Habib SS; Aslam M
    Saudi Med J; 2003 Jun; 24(6):647-51. PubMed ID: 12847596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of serum lipids and serum lipoprotein spectrum in patients with cerebrovascular diseases.
    Zhou J; Zhang M; Li XM
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Mar; 23(3):262-4. PubMed ID: 12651248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease and Lp(a) in the adult population and in the elderly: the Brisighella study.
    Nascetti S; D'Addato S; Pascarelli N; Sangiorgi Z; Grippo MC; Gaddi A
    Riv Eur Sci Med Farmacol; 1996; 18(5-6):205-12. PubMed ID: 9177623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.